東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

New anti-cancer drug development and...

Zhang, Yongchang.

Linked to FindBook

Google Book

Amazon

博客來

New anti-cancer drug development and evaluation

Record Type:	Electronic resources : Monograph/item
Title/Author:	New anti-cancer drug development and evaluation/ edited by Yongchang Zhang, Nong Yang.
other author:	Zhang, Yongchang.
Published:	Singapore :Springer Nature Singapore : : 2024.,
Description:	xxvii, 232 p. :ill., digital ;24 cm.
[NT 15003449]:	Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.
Contained By:	Springer Nature eBook
Subject:	Antineoplastic agents. -
Online resource:	https://doi.org/10.1007/978-981-97-7274-2
ISBN:	9789819772742

New anti-cancer drug development and evaluation
New anti-cancer drug development and evaluation[electronic resource] /edited by Yongchang Zhang, Nong Yang. - Singapore :Springer Nature Singapore :2024. - xxvii, 232 p. :ill., digital ;24 cm.

Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.

This book aims to help researchers to understand the current status of new drug development in China and major events experienced in the development of new drugs. It also helps clinicians and basic research scientists to grasp the types, indications, and adverse reactions of common new drugs; clarifies key events experienced during the launch of new drugs; and discusses future perspectives of clinical medicine development. This book is also beneficial to clinicians by helping them to better become physician scientists.

ISBN: 9789819772742

Standard No.: 10.1007/978-981-97-7274-2doiSubjects--Topical Terms:

795427
Antineoplastic agents.

LC Class. No.: RC271.C5

Dewey Class. No.: 615.798

New anti-cancer drug development and evaluation
LDR:01952nmm a2200325 a 4500 001 2389195
003 DE-He213
005 20241209115243.0
006 m d
007 cr nn 008maaau
008 250916s2024 si s 0 eng d
020 $a 9789819772742 $q (electronic bk.)
020 $a 9789819772735 $q (paper)
024 7 $a 10.1007/978-981-97-7274-2 $2 doi
035 $a 978-981-97-7274-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.C5
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.798 $2 23
090 $a RC271.C5 $b N532 2024
245 0 0 $a New anti-cancer drug development and evaluation $h [electronic resource] / $c edited by Yongchang Zhang, Nong Yang.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xxvii, 232 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Transformations and Challenges in Cancer Treatment -- Chapter 2. Drug(gable) Targets Discovery -- Chapter 3. Preclinical and Translational Study Design -- Chapter 4. Clinical Trials -- Chapter 5. Small Molecule Compounds -- Chapter 6. Antibodies -- Chapter 7. Cell Guided Drugs -- Chapter 8. Gene Guided Drugs -- Chapter 9. Biosimilar -- Chapter 10. New Insights on Success and Failed Drugs -- Chapter 11. The Road from Laboratory to Patient.
520 $a This book aims to help researchers to understand the current status of new drug development in China and major events experienced in the development of new drugs. It also helps clinicians and basic research scientists to grasp the types, indications, and adverse reactions of common new drugs; clarifies key events experienced during the launch of new drugs; and discusses future perspectives of clinical medicine development. This book is also beneficial to clinicians by helping them to better become physician scientists.
650 0 $a Antineoplastic agents. $3 795427
650 0 $a Cancer $x Chemotherapy. $3 753516
650 0 $a Drug development. $3 716904
650 1 4 $a Pharmacology. $3 634543
650 2 4 $a Preclinical Research. $3 3594088
650 2 4 $a Clinical Research. $3 3531315
700 1 $a Zhang, Yongchang. $3 3754774
700 1 $a Yang, Nong. $3 3754775
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-7274-2
950 $a Medicine (SpringerNature-11650)